EUVIMEDEUVIMED entdecken
Crossref

Risk Factors Influencing Medication‐Related Osteonecrosis of the Jaws ( MRONJ ) Following Dental Extraction Among Osteoporotic Patients in Taiwan

Ling-Ying Wei, Yi-Wen Cheng, Wei-Yih Chiu, Sang-Heng Kok iD, Hao-Hong Chang, Shih-Jung Cheng iD, Jang-Jaer Lee iD

Head & Neck · 2025-04 · 47 (4) · 1151-1161

DOI: 10.1002/hed.28011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 29.11.2024. Verfasst von Ling-Ying Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral and Maxillofacial Surgery, Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Tooth Extraction, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Antiresorptive therapy (ART) is commonly used in osteoporotic patients to prevent bone loss. This retrospective cohort study aimed to identify the risk factors associated with medication‐related osteonecrosis of the jaw (MRONJ) in osteoporotic patients receiving dental extraction during ART. Materials and Methods Data were collected from 937 patients with 1067 dental extractions conducted between January 2003 and May 2022, including 519 patients on oral alendronate, 276 on denosumab, and 172 on zoledronate. Multivariate logistic regression analysis was employed to assess potential risk factors.

Results

Regression model analysis revealed older age (AOR 1.09 per year; 95% CI, 1.06–1.12) and drug treatment exceeding 24 months (AOR 2.07; 95% CI, 1.29–3.30) as significant risk factors. A drug interruption of 3 or more months prior to tooth extraction lowered MRONJ risk (AOR 0.11; 95% CI, 0.07–0.17). Stratified by drug type, denosumab users had significantly lower risk of MRONJ after extraction (AOR 0.14; 95% CI, 0.07–0.27) compared to those on other medications. Factors of drug duration ≥ 24 months, < 3 months of interruption, and posterior mandibular tooth extraction posed the highest synergistic MRONJ risk (AOR 80.29; 95% CI, 33.05–195.09).

Conclusion

Our results suggest an association between a three‐month ART interruption prior to tooth extraction and reduced MRONJ risk, especially in long‐term ART patients undergoing posterior mandibular extractions. However, these findings require validation through prospective randomized controlled trials. Clinical Relevance Scientific Rationale for Study : The study fills crucial knowledge gaps regarding MRONJ risks in osteoporotic patients undergoing dental extraction during antiresorptive therapy (ART), providing a foundation for informed clinical decisions. Principal Findings : Noteworthy findings include elevated MRONJ risk with older age and prolonged ART, the protective effect of a 3‐month ART interruption, and denosumab users showing significantly reduced postextraction MRONJ risk. Practical Implications : Implementing a 3‐month ART interruption before dental extraction is recommended to reduce MRONJ occurrences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tooth ExtractionBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsOsteoporosisDenosumabHumansFemaleMaleRetrospective StudiesAgedRisk FactorsMiddle AgedTaiwanAlendronateZoledronic AcidAged, 80 and overLogistic Models

Stichwörter der Autor:innen

medication‐related osteonecrosis of the jawsosteoporotic patientsrisk factortooth extraction

Substanzen

Bone Density Conservation AgentsDenosumabAlendronateZoledronic Acid

Autor:innen und Institutionen

  • Division of Oral and Maxillofacial Surgery, Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Dentistry, School of Dentistry, College of Medicine, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Sang-Heng Kok, Shih-Jung Cheng, Jang-Jaer Lee

Zitieren

APA

Wei, L. Y., Cheng, Y. W., Chiu, W. Y., Kok, S. H., Chang, H. H., Cheng, S. J., & Lee, J. J. (2025). Risk Factors Influencing Medication‐Related Osteonecrosis of the Jaws ( MRONJ ) Following Dental Extraction Among Osteoporotic Patients in Taiwan. Head & Neck, 47(4), 1151-1161. https://doi.org/10.1002/hed.28011

Vancouver

Wei LY, Cheng YW, Chiu WY, Kok SH, Chang HH, Cheng SJ, et al. Risk Factors Influencing Medication‐Related Osteonecrosis of the Jaws ( MRONJ ) Following Dental Extraction Among Osteoporotic Patients in Taiwan. Head & Neck. 2025;47(4):1151-1161. doi:10.1002/hed.28011

BibTeX
@article{Wei2025,
  author = {Wei, Ling-Ying and Cheng, Yi-Wen and Chiu, Wei-Yih and Kok, Sang-Heng and Chang, Hao-Hong and Cheng, Shih-Jung and Lee, Jang-Jaer},
  title = {Risk Factors Influencing Medication‐Related Osteonecrosis of the Jaws ( MRONJ ) Following Dental Extraction Among Osteoporotic Patients in Taiwan},
  journal = {Head & Neck},
  year = {2025},
  volume = {47},
  number = {4},
  pages = {1151--1161},
  doi = {10.1002/hed.28011}
}
Kostenlos starten →